Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Zhiding Medical Technology (Hangzhou)

Request full access

A leading producer of optical medical equipment in China

Hangzhou, ChinaFounded 2015Health Tech & Medtech

About Zhiding Medical Technology (Hangzhou)

Zhiding Medical Technology (Hangzhou) Co., Ltd. is a Chinese high-tech enterprise focused on the research, development, manufacturing, and sales of high-precision optical medical equipment, particularly in the field of ophthalmology. The company was initially established in Nanjing in 2012, specializing in vein visualization products. In 2015, the headquarters were relocated to Hangzhou, a move that marked a strategic pivot towards comprehensive ophthalmic solutions. Zhiding Medical was founded by a group of overseas professors and brings together experts in optics and precision machinery from both China and the United States. The founder, Dr. Tang Lei, has been actively involved in discussions on medical equipment innovation and cooperation.

The company's business model revolves around the direct sale of its proprietary medical devices to healthcare providers worldwide. Its client base includes hospitals and specialized eye clinics. Zhiding Medical operates in the high-tech medical device market, with a significant emphasis on ophthalmology. Key milestones for the company include developing China's first ophthalmic Optical Coherence Tomography Angiography (OCTA) in 2016, obtaining National Class II medical machinery production licenses in 2017, and launching its widely acclaimed OCTA/OCT products in 2018. Between 2019 and 2022, the firm established the Zhiding Cloud Film Reading Center for remote OCT assistance, secured multiple rounds of funding, and entered into strategic cooperations with Lumenis and the Suzhou Institute of Biomedical Engineering Technology. In the third quarter of 2022, the company successfully completed a 50 million RMB Series B financing round.

Zhiding Medical's product portfolio addresses critical needs in diagnostics and treatment. Its core offerings include Optical Coherence Tomography (OCT) and OCTA scanners, which provide non-invasive, high-resolution imaging of retinal structures to diagnose fundus diseases. Another major focus is on dry eye disease, for which the company manufactures a comprehensive suite of products including the D500 and D600 Dry Eye Analyzers/Detectors. These devices assist in diagnosing Meibomian Gland Dysfunction (MGD) by capturing clear images of the glands and tear film. For treatment, Zhiding offers an Intense Pulsed Light (IPL) therapy system and an Atomizing Fumigator, which uses a heated, atomized mist to moisturize the eyes. The company also continues to produce its original vein visualization systems, which use infrared light to help with venipuncture.

Source: Dealroom company data

At a glance

Status
Operational
Employees
22
Open positions
None listed
Dealroom signal
26.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Ophthalmology, Medical Imaging, Health Diagnostics, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Nov 2024 $14M $55M Hyfinity Investments · Hankang Capital · Med-Fine Capital · Sunmed Capital ↗
SERIES AEquity / VC Jun 2019 $4.3M $17M Qiming Venture Partners —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Zhiding Medical Technology (Hangzhou) website traffic

Latest recorded traffic for Zhiding Medical Technology (Hangzhou) is 400 monthly website visits, down 59.6% over the last three months. Zhiding Medical Technology (Hangzhou)'s team grew 0% over the past year.

Latest monthly visits400 3-month web change-59.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Zhiding Medical Technology (Hangzhou) in the Hangzhou ecosystem

Live from Dealroom

The Zhiding Medical Technology (Hangzhou) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later4 investors entered at this stage

  • Hyfinity Investments
  • Hankang Capital
  • Med-Fine Capital
  • Sunmed Capital
Employees 22 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇨🇳 China83.3%
🇲🇽 Mexico16.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Zhiding Medical Technology (Hangzhou) on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Zhiding Medical Technology (Hangzhou)’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.